Septerna News and Activities

Septerna is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Septerna is a company listed under the stock ticker SEPN (US).

View the org chart displaying its 23 main executives

Most searched biographies at Septerna

• Jeffrey Finer, Chief Executive Officer
• Abraham Bassan, Director
• Jake Simson, Director

Popular executive movements at Septerna

• Mark Wilson has joined the company as Chief Legal Officer  (posted on January 9 2026).

Create your alert
to follow the executive moves at Septerna.

Septerna has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Septerna

• Septerna Presents New Preclinical Data at ASBMR 2024 Highlighting Therapeutic Potential of Oral Small Molecule Parathyroid Hormone 1 Receptor (PTH1R) Agonists for Hypoparathyroidism - Septerna
• Septerna Announces Initiation of Phase 1 Clinical Trial with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism - Septerna
• Septerna Marks Transition to a Clinical-Stage Company with Appointments of Industry Veterans in Key Drug Development Roles - Septerna
• Septerna Presents Preclinical Data at ENDO 2024 Highlighting Therapeutic Potential of its GPCR Drug Discovery Platform - Septerna
• Septerna to Present Preclinical Data from GPCR Drug Discovery Engine at ENDO 2024 - Septerna
• Septerna to Participate in the Jefferies Global Healthcare Conference - Septerna
• Septerna to Participate in Upcoming Investor and Industry Conferences - Septerna
• Septerna Appoints Industry Veterans Bernard Coulie, M.D., Ph.D., and Shalini Sharp to its Board of Directors - Septerna
• Septerna Bolsters Leadership Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies - Septerna
• Septerna Appoints Jeffrey Finer, MD, PhD, as Chief Executive Officer - Septerna
• View more press releases Close

Social media about Septerna

• Septerna on Wikipedia, Google News & Yahoo Finance
• Septerna on LinkedIn, X (Twitter) & YouTube